Early Screening, Innovative Solutions to Underline Importance of ADME/Tox Technologies in Successful Drug Development
Considerable Time, Cost Savings to Accrue from Advanced ADME/Tox Technologies
10-Aug-2005 -
Typically, new drug approval is a protracted, expensive and complex process. Approximately 90 per cent of clinical candidates fail during the development stage with the estimated costs due to poor absorption, distribution, metabolism, elimination (ADME) or toxicity properties itself pegged at ...
absorption
biotechnology
clinical trials
+8